Literature DB >> 33847880

Comparison of the Skin Cancer Quality of Life Impact Tool and the Skin Cancer Index Questionnaire in Measurement of Health-Related Quality of Life and the Effect of Patient Education Brochures in Patients with Actinic Keratosis, Non-melanoma, and Cutaneous Melanoma.

Sam El Abbadi1, Laura Susok2, Egger Stockfleth2, Falk Georges Bechara2, Thilo Gambichler2, Swetlana Herbrandt3, Lisa Goldschmidtböing3, Michael Sand4,5.   

Abstract

INTRODUCTION: Few studies have evaluated patient-reported outcome measures and the effect of patient educational materials in German patients with skin cancer. We conducted a prospective study to measure the impact of treatment on health-related quality of life in German patients with skin cancer, identify variables that may contribute to changes in health-related quality of life, and evaluate the effect of providing additional information through a patient education brochure.
METHODS: A total of 461 patients diagnosed with actinic keratosis, nonmetastatic nonmelanoma skin cancer, melanoma in situ, or nonmetastatic cutaneous melanoma treated between August 2018 and July 2020 were included. Ninety-seven patients were randomly selected to receive an additional patient education brochure ("Hautkrebs"). The patients completed a Skin Cancer Quality of Life Index Tool (n = 324) or a Skin Cancer Index Questionnaire (n = 137) 1 week after surgical treatment.
RESULTS: Ninety-seven patients were provided an additional patient education brochure. We found statistical correlation between sociodemographic factors (young age and female gender) and the location of the skin cancer (head and face) and impairment of health-related quality of life in patients with skin cancer (p < 0.05). Moreover, we found that patients who were presented a brochure showed significantly higher awareness concerning direct sun exposure (p < 0.05).
CONCLUSION: Impaired health-related quality of life is correlated with a patient with skin cancer's age, gender, and the location of the lesion. Physicians should consider these factors in clinical practice and advocate the use of patient education brochures as effective assets in preventing the reoccurrence of skin cancer.

Entities:  

Keywords:  Patient education brochures; Quality of life; SCIQ; SCQOLIT; Skin cancer

Year:  2021        PMID: 33847880     DOI: 10.1007/s13555-021-00522-y

Source DB:  PubMed          Journal:  Dermatol Ther (Heidelb)


  48 in total

1.  Creation of a quality of life instrument for nonmelanoma skin cancer patients.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Mary Burzynski; Ann B Nattinger
Journal:  Laryngoscope       Date:  2005-07       Impact factor: 3.325

2.  Patient quality of life fluctuates before and after Mohs micrographic surgery: A longitudinal assessment of the patient experience.

Authors:  Junqian Zhang; Christopher J Miller; Victoria O'Malley; Jeremy R Etzkorn; Thuzar M Shin; Joseph F Sobanko
Journal:  J Am Acad Dermatol       Date:  2018-03-05       Impact factor: 11.527

3.  Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.

Authors:  Mary-Margaret Chren; Anju P Sahay; Daniel S Bertenthal; Saunak Sen; C Seth Landefeld
Journal:  J Invest Dermatol       Date:  2007-02-15       Impact factor: 8.551

4.  The skin cancer index: clinical responsiveness and predictors of quality of life.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Brent R Logan; Mary Burzynski; Ann B Nattinger
Journal:  Laryngoscope       Date:  2007-03       Impact factor: 3.325

5.  Impact of melanoma on patients' lives among 562 survivors: a Dutch population-based study.

Authors:  Cynthia Holterhues; Darren Cornish; Lonneke Veronique van de Poll-Franse; Gertruud Krekels; Frans Koedijk; Danielle Kuijpers; Jan Willem Coebergh; Tamar Nijsten
Journal:  Arch Dermatol       Date:  2011-02

Review 6.  A systematic review of worldwide incidence of nonmelanoma skin cancer.

Authors:  A Lomas; J Leonardi-Bee; F Bath-Hextall
Journal:  Br J Dermatol       Date:  2012-05       Impact factor: 9.302

Review 7.  Epidemiology of skin cancer.

Authors:  Ulrike Leiter; Thomas Eigentler; Claus Garbe
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

8.  Skin cancer is among the most costly of all cancers to treat for the Medicare population.

Authors:  Tamara Salam Housman; Steven R Feldman; Phillip M Williford; Alan B Fleischer; Neal D Goldman; Jose M Acostamadiedo; G John Chen
Journal:  J Am Acad Dermatol       Date:  2003-03       Impact factor: 11.527

9.  Quality of life issues in nonmetastatic skin cancer.

Authors:  D Burdon-Jones; P Thomas; R Baker
Journal:  Br J Dermatol       Date:  2009-08-20       Impact factor: 9.302

Review 10.  Quality of life in non-melanoma skin cancer.

Authors:  Charles Gaulin; Deshan F Sebaratnam; Pablo Fernández-Peñas
Journal:  Australas J Dermatol       Date:  2014-09-08       Impact factor: 2.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.